Canary Capital launches first U.S. spot staked INJ ETF on Nasdaq, offering exposure plus staking rewards.

Ozempic market to hit $113.95B by 2032 with 24.9% CAGR driven by rising diabetes and metabolic health demand.

The Ozempic market, valued at $30.04 billion in 2026, is projected to grow to $113.95 billion by 2032, with a CAGR of 24.89%. This growth is fueled by increasing demand for diabetes and metabolic health treatments, wider adoption of GLP-1 therapies, ...